D V Medical Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—6

Registered number: 12434291

		2026		2025 as restated
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		2,470		869

			2,470		869
CURRENT ASSETS
Debtors	5	31,125		30,613
Cash at bank and in hand		22,733		13,006

		53,858		43,619
Creditors: Amounts Falling Due Within One Year	6	(7,089 )		(11,298 )

NET CURRENT ASSETS (LIABILITIES)			46,769		32,321

TOTAL ASSETS LESS CURRENT LIABILITIES			49,239		33,190

PROVISIONS FOR LIABILITIES
Deferred Taxation	7		(617 )		-

NET ASSETS			48,622		33,190

CAPITAL AND RESERVES
Called up share capital	8		300		300
Profit and Loss Account			48,322		32,890

SHAREHOLDERS' FUNDS			48,622		33,190

Page 1

Page 2

D V Medical Limited

Balance Sheet (continued)

As At 31 January 2026

For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Daniel Vaughan

Director

16/09/2026

The notes on pages 3 to 6 form part of these financial statements.

1. General Information

D V Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12434291 . The registered office is 5 Main Avenue, Peterston-Super-Ely, Vale Of Glamorgan, CF5 6LQ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Going Concern Disclosure

The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.

2.3. Turnover

Turnover represents amounts receivable for the provision of medical and sports medicine services, net of VAT where applicable. Revenue is recognised in the period in which the related services are provided. Amounts relating to services provided before the year end but not invoiced or received until after the year end are recognised as accrued income.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Office equipment	4 years
Computer Equipment	3 years

2.5. Leasing and Hire Purchase Contracts

Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the profit and loss account as incurred.

Page 3

Page 4

D V Medical Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 January 2026

2.6. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

2.7. Pensions

The company operates a defined contribution pension scheme. Contributions payable to the scheme are charged to the profit and loss account in the period to which they relate.

3. Average Number of Employees

Average number of employees during the year was: 1 (2025: 1)

4. Tangible Assets

	Office equipment	Computer Equipment	Total
	£	£	£
Cost
As at 1 February 2025	2,195	2,048	4,243
Additions	3,224	-	3,224
Disposals	-	(2,048 )	(2,048 )

As at 31 January 2026	5,419	-	5,419

...CONTINUED

Page 4

Page 5

D V Medical Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 January 2026

Depreciation
As at 1 February 2025	1,326	2,048	3,374
Provided during the period	1,623	-	1,623
Disposals	-	(2,048 )	(2,048 )

As at 31 January 2026	2,949	-	2,949

Net Book Value
As at 31 January 2026	2,470	-	2,470

As at 1 February 2025	869	-	869

5. Debtors

	2026	2025 as restated
	£	£
Due within one year
Other debtors	31,125	30,613

6. Creditors: Amounts Falling Due Within One Year

	2026	2025 as restated
	£	£
Other creditors	2,170	1,171
Taxation and social security	4,919	10,127

	7,089	11,298

7. Deferred Taxation

The provision for deferred tax is made up as follows:

	2026	2025 as restated
	£	£
Accelerated capital allowances	617	-

8. Share Capital

	2026	2025 as restated
Allotted, called up and fully paid	£	£
100 Ordinary A shares of £ 1.00 each	100	100
1,000 Ordinary B shares of £ 0.10 each	100	100
1,000 Ordinary C shares of £ 0.10 each	100	100

	300	300

Page 5

Page 6

D V Medical Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 January 2026

9. Other Commitments

The total of future minimum lease payments under non-cancellable operating leases are as following:

	2026	2025 as restated
	£	£
Not later than one year	1,694	6,774
Later than one year and not later than five years	-	1,694

	1,694	8,468

10. Directors Advances, Credits and Guarantees

During the year, the director’s loan account moved from an amount due from the director to an amount due to the director.

	As at 1 February 2025	Amounts advanced	Amounts repaid	Amounts written off	As at 31 January 2026
	£	£	£	£	£
Mr Daniel Vaughan	613	1,718	(2,624 )	-	(293 )

The above loan is unsecured, interest free and repayable on demand.

11. Related Party Transactions

At 31 January 2026, the company was owed £30,000 (2025: £30,000) by Chief Property Solutions Limited, a company under common control. The balance is unsecured, interest free and repayable on demand. No amounts were written off or provided for during the year.

12. Ultimate Controlling Party

The company is controlled by Daniel Andrew Vaughan, by virtue of his ownership of all of the company’s voting Ordinary A shares.

Page 6